Harold Bernstein - Net Worth and Insider Trading

Harold Bernstein Net Worth

The estimated net worth of Harold Bernstein is at least $0 dollars as of 2026-09-11. Harold Bernstein is the President, R&D & CMO of Maze Therapeutics Inc and owns about 0 shares of Maze Therapeutics Inc (MAZE) stock worth over $0. Details can be seen in Harold Bernstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harold Bernstein has not made any transactions after 2026-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Harold Bernstein

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Harold Bernstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harold Bernstein owns 1 companies in total, including Maze Therapeutics Inc (MAZE) .

Click here to see the complete history of Harold Bernstein’s form 4 insider trades.

Insider Ownership Summary of Harold Bernstein

Ticker Company Transaction Date Type of Owner
MAZE Maze Therapeutics Inc 2026-09-04 President & R&D & CMO

Harold Bernstein Latest Holdings Summary

Harold Bernstein currently owns a total of 1 stock. Harold Bernstein owns 0 shares of Maze Therapeutics Inc (MAZE) as of September 4, 2026, with a value of $0.

Latest Holdings of Harold Bernstein

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MAZE Maze Therapeutics Inc 2026-09-04 0 24.81 0

Holding Weightings of Harold Bernstein


Harold Bernstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Harold Bernstein has made a total of 14 transactions in Maze Therapeutics Inc (MAZE) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Maze Therapeutics Inc is the sale of 9,705 shares on September 4, 2026, which brought Harold Bernstein around $254,465.

Insider Trading History of Harold Bernstein

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harold Bernstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Harold Bernstein owns.
View MAZE Analysis

Harold Bernstein Ownership Network

Ownership Network List of Harold Bernstein

No Data

Ownership Network Relation of Harold Bernstein

Insider Network Chart


Harold Bernstein Owned Company Details

What does Maze Therapeutics Inc do?

Who are the key executives at Maze Therapeutics Inc?

Harold Bernstein is the President & R&D & CMO of Maze Therapeutics Inc. Other key executives at Maze Therapeutics Inc include CSBO Atul Dandekar , director & Chief Executive Officer Jason V Coloma , and GC and Corp. Secretary Phillips Courtney .

Maze Therapeutics Inc (MAZE) Insider Trades Summary

Over the past 18 months, Harold Bernstein made 14 insider transaction in Maze Therapeutics Inc (MAZE) with a net sale of 246,745. Other recent insider transactions involving Maze Therapeutics Inc (MAZE) include a net sale of 138,934 shares made by Atul Dandekar , a net sale of 195,144 shares made by Jason V Coloma , and a net sale of 37,500 shares made by Amy Bachrodt .

In summary, during the past 3 months, insiders sold 253,818 shares of Maze Therapeutics Inc (MAZE) in total and bought 0 shares, with a net sale of 253,818 shares. During the past 18 months, 672,473 shares of Maze Therapeutics Inc (MAZE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,473 shares.

Maze Therapeutics Inc (MAZE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Maze Therapeutics Inc Insider Transactions

No Available Data

Harold Bernstein Mailing Address

Above is the net worth, insider trading, and ownership report for Harold Bernstein. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Harold Bernstein's mailing address is: South San Francisco Ca 94080.